Business Standard

Dr Lal PathLabs, Metropolis: Here's how healthcare stocks look on charts

Thyrocare Technologies has the strong support of 50-DMA, currently placed at Rs 988 levels.

Coronavirus, covid, tests
Premium

After scaling a new all-time high, the sentiment is bullish for Metropolis Healthcare.

Avdhut Bagkar Mumbai
Shares of diagnostic and healthcare services firms such as Metropolis Healthcare, Dr Lal PathLabs, and Thyrocare Technologies were trading in the positive territory on Tuesday, a day after the Maharashtra government imposed restrictions on all air and rail passengers arriving from Delhi, Gujarat, Rajasthan, and Goa. Passengers travelling from these states — which have seen a significant surge in cases — will have to obtain a negative RT-PCR test report before starting. READ MORE

Among individual stocks, Dr Dr Lal PathLabs rallied as much as 3.57 per cent to Rs 2,375.95 on the BSE while Metropolis Healthcare

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in